Skip to main content

Media Category: x - Recorded Webinars

New insights in the 2024 McDonald criteria: imaging biomarkers shaping MS diagnosis

Written by ParadigMS Foundation on .

In this keynote lecture at the Belgian MS Symposium 2025, Pietro Maggi discussed how advanced MRI biomarkers have been integrated into the upcoming 2024 revisions of the McDonald diagnostic criteria for Multiple Sclerosis. Key Insights from the Webinar: These revisions aim to improve diagnostic precision and reduce misdiagnosis, particularly in early or atypical cases. Among the most significant updates are: Optic nerve involvement — now recognized as a fifth anatomical location for demonstrating dissemination in space (DIS), supported by MRI, visual evoked potentials (VEP), and optical...

Continue reading

Translation of 2024 MS criteria for asymptomatic individuals into clinical practice: From RIS to MS

Written by ParadigMS Foundation on .

This recording will help you refine your MS diagnostic skills with Christine Lebrun-Frenay led-insights on the 2024 McDonald criteria and practical tools for confident early detection. Key Insights from the Webinar The 2024 McDonald revision refines diagnostic clarity in Multiple Sclerosis (MS) while maintaining strong continuity with the 2017 criteria. The update aims to support earlier, more confident diagnosis, particularly for asymptomatic or preclinical cases, and to reduce over-diagnosis in patients with vascular or migraine-related MRI findings. The session highlights how these...

Continue reading

Differential diagnosis and management of NMOSD

Written by ParadigMS Foundation on .

This webinar provides a comprehensive and practical overview of neuromyelitis optica spectrum disorder (NMOSD), with a focus on differential diagnosis, pathophysiology, biomarkers, and evolving treatment strategies. Professors Melinda Magyari and Celia Oreja-Guevara guide clinicians through the complexities of distinguishing NMOSD from MS and related disorders, and present current evidence-based approaches to both acute management and long-term care—highlighting emerging therapies and patient-specific considerations. This recording will deepen your confidence in diagnosing and managing NMOSD. “Differential...

Continue reading

B-Cell therapies in the treatment of multiple sclerosis

Written by ParadigMS Foundation on .

This educational webinar explores the evolving role of B-cell therapies in the treatment of multiple sclerosis (MS). Professors Celia Oreja-Guevara and Patrick Vermersch provide a comprehensive overview of B-cell immunology, mechanisms of action of anti-CD20 monoclonal antibodies, and the latest clinical evidence supporting their use across relapsing and progressive forms of MS. The session also discusses comparative data on efficacy, safety, administration routes, and long-term patient outcomes, offering clinicians practical guidance for therapeutic decision-making. Watch the full webinar...

Continue reading

New diagnostic criteria for MS

Written by Karolina Kowalska on .

Curious about what’s new in the 2024 McDonald diagnostic criteria for MS? In this expert-led session, Professors Celia Oreja-Guevara and Bassem Yamout, ParadigMS Experts, walk you through the latest updates, including optic nerve involvement, advanced imaging biomarkers, and refined strategies for diagnosing MS in complex cases.Watch now to stay current and sharpen your clinical practice. “New diagnostic criteria for MS“. Please subscribe to watch. Find out about the speakers: Prof. Celia Oreja-Guevara Prof. Bassem Yamout

Continue reading

Safety tests in the clinical management of MS

Written by ParadigMS Foundation on .

Enhance your understanding of safety tests in the clinical management of MS with Prof. Tjalf Ziemssen and Prof. Magd Zakaria. This webinar explores the crucial role of safety monitoring in MS treatment, covering key topics such as liver enzyme and lymphocyte testing, ATZ monitoring, JCV testing for PML risk, and more. Watch the recording at your convenience and learn from the latest developments on optimising treatment strategies and ensuring patient safety. “Safety tests in the clinical management of MS“. Please subscribe to watch. Find out about...

Continue reading

FAQs

Is ParadigMS for free?

Yes, a ParadigMS subscription is free for healthcare practitioniers. 

Do subscriptions auto-renew?
Your subscription will automatically renew on yearly basis. If you cancel your plan, it will not renew at the end of your subscription cycle. 
I am a representative from industry, can I subscribe?

Free subscriptions to ParadigMS are reserved for healthcare practitioners. If you are a representative of the industry please contact us on learning@paradigms.foundation and we would advise you how to get the access to the material. 

What happens if I subscribe as a HCP if I am not?
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, we will cancel your subscription immediately. 
I am a patient, can I subscribe?

ParadigMS is designed specifically for healthcare practitioners, with content and language tailored to their professional needs. While patients cannot subscribe directly, we encourage you to consult your healthcare provider for relevant insights and updates that may benefit you.

Why should I subscribe to ParadigMS's e-platform?

Subscribing to ParadigMS’s e-platform gives you access to up-to-date information and valuable learning materials on multiple sclerosis and NMO, along with expert insights and the latest innovations in the field. It’s an essential resource for staying informed and enhancing your knowledge in MS care.

How can I cancel my subscription?
You can cancel your subscription in your account settings. 
Can I financially support ParadigMS?

Yes, you can financially support ParadigMS! We welcome donations to help us continue our mission of advancing multiple sclerosis education and research. Your contribution directly supports the creation of educational resources, expert discussions, and innovative projects in MS care. Visit our donation page to learn more about how you can make a difference: ParadigMS Donate.